This post has been archived and contains information that may be out of date.
CHA this week attended a stakeholder meeting held by the Food and Drug Administration (FDA) on the root cause of drug shortages. Ahead of the meeting, CHA submitted a comment letter that identifies underlying systemic causes and makes recommendations to prevent or mitigate drug shortages.
The FDA notes that Congress has asked it to examine the causes of these shortages and recommend measures that will provide enduring solutions. The FDA has also convened an inter-agency task force that will issue a report to Congress following the stakeholder meeting and the receipt of additional comments, which may be submitted to the agency until Jan. 11.
CHA appreciates the opportunity to provide input on the continuing impact of drug shortages within our hospitals and urges immediate action to address this public health crisis. CHA encourages hospitals to submit comments on the effects drug shortages have on their patients before the Jan. 11 comment deadline. Comments can be submitted at regulations.gov.
